Vitamins that may be helpful
Deficiencies of iron, vitamin B12, and folic acid are the most common nutritional causes of
anemia.4 Although rare, severe deficiencies of several other vitamins and minerals,
including vitamin A,5 6
vitamin B2,7 vitamin B6,8 9 vitamin C,10 and copper,11 12 can also cause
anemia by various mechanisms. Rare genetic disorders can cause anemias that may improve with
large amounts of supplements such as vitamin
B1.13 14
Taurine has been shown, in a double-blind study, to improve the response to iron therapy in
young women with iron-deficiency anemia.15 The amount of taurine used was 1,000 mg
per day for 20 weeks, given in addition to iron therapy, but at a different time of the day.
The mechanism by which taurine improves iron utilization is not known.
Hemolytic anemia refers to a category of anemia in which red blood cells become fragile and
undergo premature death. Vitamin E deficiency,
though quite rare, can cause hemolytic anemia because vitamin E protects the red blood cell
membrane from oxidative damage. Vitamin E deficiency anemia usually affects only premature
infants and children with cystic
fibrosis.16 17 Preliminary studies have reported that large amounts
(typically 800 IU per day) of vitamin E improve hemolytic anemia caused by a genetic
deficiency of the enzyme glucose-6-phosphate dehydrogenase (G6PD)18 19
20 and anemia caused by kidney dialysis.21 22
People with severe thalassemia who receive regular blood transfusions become overloaded
with iron, which increases damaging free radical activity and lowers antioxidant levels in their bodies.23
24 25 26 Some people with milder forms of thalassemia may also
have iron overload.27 Iron supplements should be avoided by people with thalassemia
unless iron deficiency is diagnosed.
Preliminary studies have found that oral supplements of 200 to 600 IU per day of vitamin E reduce free radical damage to red blood
cells in thalassemia patients.28 29 30 However, only
injections of vitamin E have reduced the need for blood transfusions caused by
thalassemia.31 32
Test tube studies have shown that propionyl-L-carnitine (a form of L-carnitine) protects red blood cells of people with
thalassemia against free radical damage.33 In a preliminary study, children with
beta thalassemia major who took 100 mg of L-carnitine per 2.2 pounds of body weight per day
for three months had a significantly decreased need for blood transfusions.34 Some
studies have found people with thalassemia to be frequently deficient in folic acid, vitamin B12,35 and zinc.36 37 Researchers have
reported improved growth rates in zinc-deficient thalassemic children who were given zinc
supplements of 22.5 to 90 mg per day, depending on age.38 39 Magnesium has been reported to be low in thalassemia
patients in some,40 41 but not all,42 studies. A small,
preliminary study reported that oral supplements of magnesium, 7.2 mg per 2.2 pounds of body
weight per day, improved some red blood cell abnormalities in thalassemia
patients.43
Sideroblastic anemia refers to a category of anemia featuring a buildup of iron-containing
immature red blood cells (sideroblasts). One type of sideroblastic anemia is due to a genetic
defect in an enzyme that uses vitamin B6 as a
cofactor.44 45 Vitamin B6 supplements of 50 to 200 mg per day partially
correct the anemia, but must be taken for life.46
Are there any side effects or interactions?
Refer to the individual supplement for information about any side effects or interactions.
1. Smith JA. Exercise, training and red blood cell turnover. Sports
Med 1995;19:9–31 [review].
2. Torun B, Chew F. Protein-energy malnutrition. In Shils ME, Olsen JA,
Shike M, Ross AC, eds. Modern Nutrition in Health and Disease, 9th ed. Baltimore:
Williams & Wilkins, 1999, 963–88 [review].
3. Fuchs GJ, Tienboon P, Linpisarn S, et al. Nutritional factors and
thalassaemia major. Arch Dis Child 1996;74:224–7.
4. Little DR. Ambulatory management of common forms of anemia. Am Fam
Physician 1999;59:1598–604 [review].
5. Hodges RE, Sauberlich HE, Canham JE, et al. Hematopoietic studies in
vitamin A deficiency. Am J Clin Nutr 1978;31:876–85 [review].
6. Bloem MW. Interdependence of vitamin A and iron: an important
association for programmes of anaemia control. Proc Nutr Soc 1995;54:501–8
[review].
7. Lane M, Alfrey CP. The anemia of human riboflavin deficiency.
Blood 1965;25:432–42.
8. Orehek AJ, Kollas CD. Refractory postpartum anemia due to vitamin B6
deficiency. Ann Intern Med 1997;126(10):834–5 [letter].
9. Iwama H, Iwase O, Hayashi S, et al. Macrocytic anemia with
anisocytosis due to alcohol abuse and vitamin B6 deficiency. Rinsho Ketsueki
1998;39:1127–30 [in Japanese].
10. Hirschmann JV, Raugi GJ. Adult scurvy. J Am Acad Dermatol
1999;41:895–906 [review].
11. Summerfield AL, Steinberg FU, Gonzalez JG. Morphologic findings in
bone marrow precursor cells in zinc-induced copper deficiency anemia. Am J Clin
Pathol 1992;97:665–8.
12. Freycon F, Pouyau G. Rare nutritional deficiency anemia: deficiency
of copper and vitamin E. Sem Hop 1983;59:488–93 [review] [in French].
13. Borgna-Pignatti C, Marradi P, Pinelli L, et al. Thiamine-responsive
anemia in DIDMOAD syndrome. J Pediatr 1989;114:405–10.
14. Neufeld EJ, Mandel H, Raz T, et al. Localization of the gene for
thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by
homozygosity mapping. Am J Hum Genet 1997;61:1335–41.
15. Sirdah MM, El-Agouza IMA, Abu Shahla ANK. Possible ameliorative
effect of taurine in the treatment of iron-deficiency anaemia in female university students of
Gaza, Palestine. Eur J Haematol 2002;69:236–2.
16. Mino M. Clinical uses and abuses of vitamin E in children. Proc
Soc Exp Biol Med 1992;200:266–70 [review].
17. Swann IL, Kendra JR. Anaemia, vitamin E deficiency and failure to
thrive in an infant. Clin Lab Haematol 1998;20:61–3.
18. Hafez M, Amar ES, Zedan M, et al. Improved erythrocyte survival with
combined vitamin E and selenium therapy in children with glucose-6-phosphate dehydrogenase
deficiency and mild chronic hemolysis. J Pediatr 1986;108:558–61.
19. Corash L, Spielberg S, Bartsocas C, et al. Reduced chronic hemolysis
during high-dose vitamin E administration in Mediterranean-type glucose-6-phosphate
dehydrogenase deficiency. N Engl J Med 1980;303:416–20.
20. Eldamhougy S, Elhelw Z, Yamamah G, et al. The vitamin E status among
glucose-6 phosphate dehydrogenase deficient patients and effectiveness of oral vitamin E.
Int J Vitam Nutr Res 1988;58:184–8.
21. Ono K. Reduction of osmotic haemolysis and anaemia by high dose
vitamin E supplementation in regular haemodialysis patients. Proc Eur Dial Transplant
Assoc Eur Ren Assoc 1985;21:296–9.
22. Ono K. Effects of large dose vitamin E supplementation on anemia in
hemodialysis patients. Nephron 1985;40:440–5.
23. Livrea MA, Tesoriere L, Pintaudi AM, et al. Oxidative stress and
antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble
antioxidants. Blood 1996;88:3608–14.
24. Loebstein R, Lehotay DC, Luo X, et al. Diabetic nephropathy in
hypertransfused patients with beta-thalassemia. The role of oxidative stress. Diabetes
Care 1998;21:1306–9.
25. Livrea MA, Tesoriere L, Maggio A, et al. Oxidative modification of
low-density lipoprotein and atherogenetic risk in beta-thalassemia. Blood
1998;92:3936–42.
26. De Luca C, Filosa A, Grandinetti M, et al. Blood antioxidant status
and urinary levels of catecholamine metabolites in beta-thalassemia. Free Radic Res
1999;30:453–62.
27. Da Fonseca SF, Kimura EY, Kerbauy J. Assessment of iron status in
individuals with heterozygotic beta-thalassemia. Rev Assoc Med Bras
1995;41:203–6 [in Portuguese].
28. Miniero R, Canducci E, Ghigo D, et al. Vitamin E in beta-thalassemia.
Acta Vitaminol Enzymol 1982;4:21–5.
29. Giardini O, Cantani A, Donfrancesco A, et al. Biochemical and
clinical effects of vitamin E administration in homozygous beta-thalassemia. Acta
Vitaminol Enzymol 1985;7:55–60.
30. Suthutvoravut U, Hathirat P, Sirichakwal P, et al. Vitamin E status,
glutathione peroxidase activity and the effect of vitamin E supplementation in children with
thalassemia. J Med Assoc Thai 1993;76 Suppl 2:146–52.
31. Giardini O, Cantani A, Donfrancesco A, et al. Biochemical and
clinical effects of vitamin E administration in homozygous beta-thalassemia. Acta
Vitaminol Enzymol 1985;7:55–60.
32. Miniero R, Canducci E, Ghigo D, et al. Vitamin E in beta-thalassemia.
Acta Vitaminol Enzymol 1982;4:21–5.
33. Palmieri L, Ronca F, Malengo S, Bertelli A. Protection of
beta-thalassaemic erythrocytes from oxidative stress by propionyl carnitine. Int J Tissue
React 1994;16:121–9.
34. Yesilipek MA, Hazar V, Yegin O. L-Carnitine treatment in beta
thalassemia major. Acta Haematol 1998;100:162–3.
35. Saraya AK, Kumar R, Kailash S, Sehgal AK. Vitamin B12 and folic acid
deficiency in b-heterozygous thalassemia. Indian J Med Res 1984;79:783–8.
36. Silprasert A, Laokuldilok T, Kulapongs P. Zinc deficiency in
b-thalassemic children. In Fucharoen S, Rowley PT, Paul NW, eds. Thalassemia:
pathophysiology and management, part A. New York: Alan R Liss, 1988 [review].
37. Bashir NA. Serum zinc and copper levels in sickle cell anaemia and
beta-thalassaemia in North Jordan. Ann Trop Paediatr 1995;15:291–3.
38. Arcasoy A, Cavdar AO, Cin S, et al. Effects of zinc supplementation
on linear growth in beta thalassemia. Am J Hematol 1987;24:127–36.
39. Akar N, Berberoglu M, Arcasoy A. Effects of zinc supplementation on
somatomedin-C level, in beta-thalassemia. Am J Hematol 1992;41:142–3
[letter].
40. Cohen L, Bitterman H, Froom P, Aghai E. Decreased bone magnesium in
beta thalassemia with spinal osteoporosis. Magnesium 1986;5:43–6.
41. Hyman CB, Ortega JA, Costin G, Takahashi M. The clinical significance
of magnesium depletion in thalassemia. Ann N Y Acad Sci 1980;344:436–43.
42. Arcasoy A, Cavdar AO. Changes of trace minerals (serum iron, zinc,
copper and magnesium) in thalassemia. Acta Haematol 1975;53:341–6.
43. De Franceschi L, Cappellini MD, Graziadei G, et al. The effect of
dietary magnesium supplementation on the cellular abnormalities of erythrocytes in patients
with beta thalassemia intermedia. Haematologica 1998;83:118–25.
44. May A, Bishop DF. The molecular biology and pyridoxine responsiveness
of X-linked sideroblastic anaemia. Haematologica 1998;83:56–70 [review].
45. May A, Fitzsimons E. Sideroblastic anaemia. Baillieres Clin
Haematol 1994;7:851–79 [review].
46. Kasdan TS. Medical nutrition therapy for anemia. In Mahan LK,
Escott-Stump S, eds. Krause’s Food, Nutrition & Diet Therapy, 10th ed.
Philadelphia: W.B. Saunders, 2000, 796–7.
47. Yuyama LKO, Dias RR, Nagahama D, et al. Acai ( Euterpe oleracea
Mart.) and camu-camu (Myrciaria dubia (H.B.K.) Mc Vaugh), do they possess anti-anemic action?
Acta Amazonica 2002;32:625–33.